390,241 Shares in Ardent Health, Inc. $ARDT Bought by Bank of America Corp DE

Key Points

• Bank of America acquired 390,241 Ardent Health shares in the second quarter, worth approximately $3.84 million and representing about 0.28% of the company. Other institutional investors, including BlackRock and Algert Global, also increased or initiated positions.
• Analyst sentiment is mixed but leans positive: seven analysts rate Ardent Health a Buy, six a Hold, and two a Sell. The consensus rating is Hold, with an average price target of $12.79 versus the reported share price of $10.62.
• Ardent Health reported quarterly revenue of $1.62 billion, exceeding estimates, but its $0.12 EPS fell short of the $0.18 consensus forecast. The company maintains fiscal 2026 EPS guidance of $0.78 to $1.15.

Bank of America Corp DE acquired a new position in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 390,241 shares of the company's stock, valued at approximately $3,840,000. Bank of America Corp DE owned about 0.28% of Ardent Health at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in Ardent Health during the second quarter valued at approximately $21,415,000. Algert Global LLC increased its stake in Ardent Health by 1,277.3% in the second quarter. Algert Global LLC now owns 597,745 shares of the company's stock valued at $5,882,000 after purchasing an additional 554,345 shares in the last quarter. First Trust Advisors LP raised its holdings in Ardent Health by 70.9% in the first quarter. First Trust Advisors LP now owns 478,795 shares of the company's stock worth $4,098,000 after purchasing an additional 198,595 shares during the period. Wedge Capital Management L L P NC boosted its position in shares of Ardent Health by 212.3% during the second quarter. Wedge Capital Management L L P NC now owns 327,242 shares of the company's stock worth $3,220,000 after purchasing an additional 222,447 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of Ardent Health during the second quarter worth $2,377,000.

Analyst Ratings Changes

A number of analysts recently issued reports on ARDT shares. Royal Bank Of Canada increased their target price on Ardent Health from $12.00 to $13.00 and gave the stock an "outperform" rating in a research note on Monday, August 10th. Truist Financial upped their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company a "buy" rating in a report on Thursday, August 6th. Zacks Research raised shares of Ardent Health from a "strong sell" rating to a "hold" rating in a research report on Monday, September 7th. BMO Capital Markets assumed coverage on shares of Ardent Health in a report on Tuesday, September 22nd. They set a "market perform" rating and a $11.00 price objective on the stock. Finally, Weiss Ratings cut shares of Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a research report on Tuesday, August 11th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ardent Health has a consensus rating of "Hold" and a consensus target price of $12.79.

Ardent Health Price Performance

Shares of ARDT opened at $10.62 on Wednesday. The stock has a market capitalization of $1.50 billion, a P/E ratio of 19.31, a P/E/G ratio of 2.96 and a beta of 0.71. Ardent Health, Inc. has a twelve month low of $7.71 and a twelve month high of $15.48. The company has a 50 day moving average of $10.87 and a 200-day moving average of $9.97. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.06). The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. As a group, equities research analysts forecast that Ardent Health, Inc. will post 0.96 EPS for the current fiscal year.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.